Mortality associated with a diagnosis of Guillain-Barré syndrome in adults of Mexican health institutions;Mortalidad asociada al diagnóstico de síndrome de Guillain-Barré en adultos ingresados en instituciones del sistema sanitario Mexicano

Revista de Neurologia

Volumn 58, Issue 1, 2014, Pages 4-10

  Domínguez Moreno, Rogelio ^a   Tolosa Tort, Paulina ^a   Patiño Tamez, Anais ^b   Quintero Bauman, Alejandra ^b   Collado Frías, Deisy K ^c   Miranda Rodríguez, María G ^c   Canela Calderón, Obet J ^d   Hurtado Valadez, Pablo ^b   de Gante Castro, Raúl ^e   Ortiz Guillén, Karoll M ^c   Estañol Vidal, Bruno ^a   Sentíes Madrid, Horacio ^a   García Ramos, Guillermo ^a   Cantú Brito, Carlos ^a   Ruiz Sandoval, José Luis ^f   Chiquete, Erwin ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE BAJA CALIFORNIA   (Mexico)

^c UNIVERSIDAD JUÁREZ AUTÓNOMA DE TABASCO   (Mexico)

^d INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^e UNIVERSIDAD AUTÓNOMA DE YUCATÁN   (Mexico)

^f HOSPITAL CIVIL DE GUADALAJARA FRAY ANTONIO ALCALDE   (Mexico)

Author keywords

Climate; Epidemiology; Guillain Barr syndrome; Mexico; Mortality

Indexed keywords

ADULT; AGE; ARTICLE; DISEASE ASSOCIATION; FEMALE; GUILLAIN BARRE SYNDROME; HOSPITALIZATION; HUMAN; ICD-10; MAJOR CLINICAL STUDY; MALE; MEXICO; MORTALITY;

ADULT; AGED; FEMALE; GEOGRAPHIC MAPPING; GUILLAIN-BARRE SYNDROME; HOSPITAL MORTALITY; HOSPITALIZATION; HOSPITALS, PUBLIC; HUMANS; KAPLAN-MEIER ESTIMATE; LENGTH OF STAY; MALE; MEXICO; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; RETROSPECTIVE STUDIES; SEASONS;

EID: 84891650829     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.5801.2013370     Document Type: Article

References (43)

1. Hughes RAC, Swan AV, Raphaël JC, Annane D, Van Koningsveld R, Van Doorn PA. Immunotherapy for Guillain- Barré syndrome: a systematic review. Brain 2007; 130: 2245-57.
2. Chroni E, Papapetropoulos S, Gioldasis G, Ellul J, Diamadopoulos N, Papapetropoulos T. Guillain-Barré syndrome in Greece: seasonality and other clinico-epidemiological features. Eur J Neurol 2004; 11: 383-8.
3. Van Koningsveld R, Van Doorn PA, Schmitz PI, Ang CW, Van der Meche FG. Mild forms of Guillain-Barré syndrome in an epidemiologic survey in The Netherlands. Neurology 2000; 54: 620-5.
4. Prevots DR, Sutter RW. Assessment of Guillain-Barré syndrome mortality and morbidity in the United States: implications for acute flaccid paralysis surveillance. J Infect Dis 1997; 175 (Suppl 1): S151-5.
5. McCrogan A, Maddle GC, Seaman HE, De Vries CS. The epidemiology of Guillain-Barré syndrome worldwide: a systematic literature review. Neuroepidemiology 2009; 32: 150-63.
6. Hadden RDM, Cornblath DR, Hughes RAC, Zielasek J, Hartung HP, Toyka KV, et al. Electrophysiological classification of Guillain-Barré syndrome. Ann Neurol 1998; 44: 780-8.
7. McKhann GM, Cornblath DR, Griffin JW, Ho TW, Li CY, Jiang Z, et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 1993; 33: 333-42.
8. Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW, et al. Guillain-Barré syndrome in northern China: relationship to Campylobacter jejuni infection and antiglycolipid antibodies. Brain 1995; 118: 597-605.
9. Nagasawa K, Kuwabara S, Misawa S, Fujii K, Tanabe Y, Yuki N, et al. Electrophysiological subtypes and prognosis of childhood Guillain-Barré syndrome in Japan. Muscle Nerve 2006; 33: 766-70.
10. Ramos-Álvarez M, Bessudo L, Sabin AB. Paralytic syndromes associated with noninflammatory cytoplasmic or nuclear neuronopathy. Acute paralytic disease in Mexican children, neuropathologically distinguishable from Landry-Guillain- Barré syndrome. JAMA 1969; 207: 1481-92.
11. Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: a systematic review and metaanalysis. Neuroepidemiology 2011; 36: 123-33.
12. Sistema Nacional de Información en Salud (SINAIS). Base de datos sobre altas hospitalarias 2010. URL: http://www.sinais.salud.gob.mx/basesdedatos/std_egresoshospitalarios.html. [21.07.2012].
13. Walling AD, Gretchen D. Guillain Barré syndrome. Am Fam Physician 2013; 87: 191-7.
14. Zhong M, Fang-Cheng C. Current perspectives on Guillain-Barré syndrome. World J Pediatr 2007; 3: 187-94.
15. Dhar R, Stitt L, Hahn AF. The morbidity and outcome of patients with Guillain-Barré syndrome admitted to the intensive care unit. J Neurol Sci 2008; 264: 121-8.
16. Van der Meché F, Schmitz P, For the Dutch Guillain-Barré Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. N Engl J Med 1992; 326: 1123-9.
17. Kieseier BC, Hartung HP. Therapeutic strategies in the Guillain-Barré syndrome. Semin Neurol 2003; 23: 159-67.
18. Pritchard J, Hughes RAC. Guillain-Barré syndrome. Lancet 2004; 363: 2186-8.
19. Alshekhlee A, Hussain Z, Sultan B, Katirji B. Guillain-Barré syndrome: incidence and mortality rates in US hospitals. Neurology 2008; 70: 1608-13.
20. Isaza-Jaramillo SP, Perez-Salazar AB, Uribe CS. Descripcion de los casos de sindrome de Guillain-Barre en el Hospital San Vicente de Paul entre los anos 2001 y 2005. Acta Neurol Colomb 2009; 25: 123-9.
21. Lyu RK, Tang LM, Cheng SY, Hsu WC, Chen ST. Guillain- Barre syndrome in Taiwan: a clinical study of 167 patients. J Neurol Neurosurg Psychiatry 1997; 63: 494-500.
22. Aladro-Benito Y, Conde-Sendin MA, Munoz-Fernandez C, Perez-Correa S, Alemany-Rodriguez MJ, Fiuza-Perez MD, et al. Sindrome de Guillain-Barre en el area norte de Gran Canaria e isla de Lanzarote. Rev Neurol 2002; 35: 705-10.
23. Rees JH, Thompson RD, Hughes RAC. Epidemiological study of Guillain-Barre syndrome in Southeast England. J Neurol Neurosurg Psychiatry 1998; 64: 74-7.
24. Winer JB, Hughes RAC, Osmond C. A prospective study of acute idiopathic neuropathy. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry 1988; 51: 605-12.
25. Kushnir M, Klein C, Pollak L, Rabey JM. Evolving pattern of Guillain-Barre syndrome in a community hospital in Israel. Acta Neurol Scand 2008; 117: 347-50.
26. Nachamkin I, Arzarte-Barbosa P, Ung H, Lobato C, Gonzalez- Rivera A, Rodriguez P, et al. Patterns of Guillain-Barre syndrome in children: results from a Mexican population. Neurology 2007; 69: 1665-71.
27. Dourado ME, Felix RH, Da Silva WK, Queiroz JW, Jeronimo SM. Clinical characteristics of Guillain-Barre syndrome in a tropical country: a Brazilian experience. Acta Neurol Scand 2012; 125: 47-53.
28. Van den Berg B, Bunschoten C, Van Doorn PA, Jacobs BC. Mortality in Guillain-Barre syndrome. Neurology 2013; 80: 1650-4.
29. Rajabally YA, Uncini A. Outcome and its predictors in Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 2012; 83: 711-8.
30. Van Koningsveld R, Rico R, Gerstenbluth I, Schmitz PI, Ang CW, Merkies IS, et al. Gastroenteritis-associated Guillain-Barre syndrome on the Caribbean island Curacao. Neurology 2001; 56: 1467-72.
31. Radhakrishnan K, El-Mangoush MA, Rerryo SE. Descriptive epidemiology of selected neuromuscular disorders in Benghazi, Libya. Acta Neurol Scand 1987; 75: 95-100.
32. Arami MA, Yazdchi M, Khandaghi R. Epidemiology and characteristics of Guillain-Barre syndrome in the northwest of Iran. Ann Saudi Med 2006; 26: 22-7.
33. Winner SJ, Evans JG. Age specific incidence of Guillain-Barre syndrome in Oxfordshire. Q J Med 1990; 77: 1297-304.
34. Congia S, Melis M, Carboni MA. Epidemiologic and clinical features of the Guillain-Barre syndrome in Sardinia in the 1961-1980 period. Acta Neurol 1989; 11: 15-20.
35. Larson JP, Kvale G, Nyland H. Epidemiology of the Guillain- Barre syndrome in the county of Hordaland, Western Norway. Acta Neurol Scand 1985; 71: 43-7.
36. Rocha MS, Brucki SM, Carvalho AA, Lima UW. Epidemiologic features of Guillain-Barre syndrome in Sao Paulo, Brazil. Arq Neuropsiquiatr 2004; 62: 33-7.
37. Jiang GX, Cheng Q, Link H, De Pedro-Cuesta J. Epidemiological features of Guillain-Barre syndrome in Sweden 1978-1993. J Neurol Neurosurg Psychiatry 1997; 62: 447-53.
38. Zuniga-Gonzalez EA, Rodriguez de la Cruz A, Millan- Padilla J. Subtipos electrofisiologicos del sindrome de Guillain-Barre en adultos mexicanos. Rev Med Inst Mex Seguro Soc 2007; 45: 463-8.
39. Carrillo-Perez DL, Garcia-Ramos G, Ruano-Calderon LA, Sosa-Hernandez JL, Mendez-Castillo JJ. Sindrome de Guillain- Barre en un hospital de referencia en Mexico. Rev Mex Neuroci 2012; 13: 15-21.
40. Tellez-Zenteno JF, Jacinto-Tinajero JC, Avila-Funes A, Garcia-Ramos G, Negrete-Pulido O, Senties-Madrid H. Guillain-Barre syndrome. Experience in a third level hospital. Rev Invest Clin 2001; 53: 311-4.
41. Lestayo-O'Farrill Z, Hernandez-Caceres JL. Analisis del comportamiento del sindrome de Guillain-Barre. Consensos y discrepancias. Rev Neurol 2008; 46: 230-7.
42. Hughes RA, Rees JH. Clinical and epidemiologic features of Guillain-Barre syndrome. J Infect Dis 1997; 176: S92-8.
43. Lopez-Esteban P, Gallego I, Gil-Ferrer V. Criterios neurofisiologicos en el sindrome de Guillain-Barre infantil. Ocho anos de experiencia. Rev Neurol 2013; 56: 275-82.